Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
125
Top-10 weight
45.72%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
32
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1214.6
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 372,144 | $342.29M | 9.44% |
| 2 | JOHNSON&JOHNSON | — | 1,131,730 | $276.64M | 7.63% |
| 3 | ABBVIE INC | — | 829,997 | $180.52M | 4.98% |
| 4 | ASTRAZENECA PLC | — | 745,465 | $145.77M | 4.02% |
| 5 | MERCK & CO | — | 1,192,992 | $143.51M | 3.96% |
| 6 | Novartis AG (Registered) | NVSEF | 913,813 | $140.27M | 3.87% |
| 7 | ROCHE HOLDING AG | — | 337,676 | $134.76M | 3.72% |
| 8 | UNITEDHEALTH GRP | — | 435,399 | $117.81M | 3.25% |
| 9 | AMGEN INC | — | 258,827 | $91.07M | 2.51% |
| 10 | THERMO FISHER SCIENTIFIC INC | — | 180,589 | $88.76M | 2.45% |
| 11 | ABBOTT LABS | — | 835,802 | $85.81M | 2.37% |
| 12 | GILEAD SCIENCES INC | — | 596,340 | $83.11M | 2.29% |
| 13 | INTUITIVE SURGICAL INC | — | 170,701 | $78.69M | 2.17% |
| 14 | PFIZER INC | — | 2,732,853 | $76.74M | 2.12% |
| 15 | BRISTOL-MYERS SQUIBB CO | — | 978,842 | $59.37M | 1.64% |
| 16 | DANAHER CORP | — | 302,406 | $57.34M | 1.58% |
| 17 | NOVO NORDISK-B | — | 1,530,419 | $56.00M | 1.55% |
| 18 | VERTEX PHARMACEUTICALS INC | — | 122,095 | $54.52M | 1.50% |
| 19 | STRYKER CORP | — | 165,557 | $54.40M | 1.50% |
| 20 | GSK PLC | — | 1,959,178 | $53.97M | 1.49% |
| 21 | MEDTRONIC PLC | — | 616,203 | $53.39M | 1.47% |
| 22 | MCKESSON CORP | — | 58,928 | $50.99M | 1.41% |
| 23 | Sanofi SA | — | 515,822 | $49.81M | 1.37% |
| 24 | BOSTON SCIENTIFIC CORP | — | 712,828 | $44.73M | 1.23% |
| 25 | CVS HEALTH CORP | — | 611,490 | $43.92M | 1.21% |
| 26 | REGENERON PHARMACEUTICALS INC | — | 48,287 | $37.31M | 1.03% |
| 27 | HCA HEALTHCARE INC | — | 75,242 | $35.61M | 0.98% |
| 28 | THE CIGNA GROUP | — | 126,718 | $33.80M | 0.93% |
| 29 | ESSILORLUXOTTICA | — | 140,292 | $32.69M | 0.90% |
| 30 | ELEVANCE HEALTH INC | — | 105,796 | $30.97M | 0.85% |
| 31 | CENCORA INC | — | 93,512 | $29.38M | 0.81% |
| 32 | TAKEDA PHARMACEU | — | 768,492 | $28.30M | 0.78% |
| 33 | HOYA CORP | — | 162,800 | $28.22M | 0.78% |
| 34 | ZOETIS INC CL A | — | 202,898 | $23.98M | 0.66% |
| 35 | CARDINAL HEALTH INC | — | 113,115 | $23.90M | 0.66% |
| 36 | CSL LTD COMMON STOCK | CSL | 233,192 | $22.90M | 0.63% |
| 37 | EDWARDS LIFESCIENCES CORP | — | 278,323 | $22.29M | 0.62% |
| 38 | Bayer Aktiengesellschaft | BAYN | 472,204 | $21.85M | 0.60% |
| 39 | LONZA GROUP -REG | — | 33,764 | $21.66M | 0.60% |
| 40 | ARGENX SE | — | 29,750 | $21.59M | 0.60% |
| 41 | IDEXX LABS INC | — | 38,388 | $21.57M | 0.60% |
| 42 | BECTON DICKINSON and CO | — | 136,872 | $21.52M | 0.59% |
| 43 | HALEON PLC | — | 4,281,064 | $21.19M | 0.58% |
| 44 | BlackRock Cash Funds: Institutional, SL Agency Shares | BISXX | 20,148,957 | $20.15M | 0.56% |
| 45 | ALCON INC | — | 240,185 | $18.16M | 0.50% |
| 46 | OTSUKA HOLDINGS | — | 247,900 | $17.59M | 0.49% |
| 47 | UCB SA | — | 57,975 | $17.47M | 0.48% |
| 48 | GALDERMA GRP. AG | GDERF | 87,980 | $17.29M | 0.48% |
| 49 | CHUGAI PHARMA CO | — | 309,800 | $17.08M | 0.47% |
| 50 | SANDOZ GROUP AG | — | 211,490 | $16.57M | 0.46% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.